Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation: Balancing Proven Clinical Benefits and Cardiotoxicity
Canadian Journal of Cardiology · 2026-09 · 42 (9) · 1945-1947
DOI: 10.1016/j.cjca.2026.04.016 ↗Kurz gefasst
Editorial in der Zeitschrift Canadian Journal of Cardiology, 2026-09. Verfasst von Hasrit Sidhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada; St Paul's Hospital, Providence Health Care, Vancouver, B…. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada; St Paul's Hospital, Providence Health Care, Vancouver, British Columbia, Canada.
- Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada; St Paul's Hospital, Providence Health Care, Vancouver, British Columbia, Canada. Electronic address: mustafa.toma@phc.ca.
Zitieren
APA
Sidhu, H., & Toma, M. (2026). Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation: Balancing Proven Clinical Benefits and Cardiotoxicity. Canadian Journal of Cardiology, 42(9), 1945-1947. https://doi.org/10.1016/j.cjca.2026.04.016
Vancouver
Sidhu H, Toma M. Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation: Balancing Proven Clinical Benefits and Cardiotoxicity. Canadian Journal of Cardiology. 2026;42(9):1945-1947. doi:10.1016/j.cjca.2026.04.016
BibTeX
@article{Sidhu2026,
author = {Sidhu, Hasrit and Toma, Mustafa},
title = {Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation: Balancing Proven Clinical Benefits and Cardiotoxicity},
journal = {Canadian Journal of Cardiology},
year = {2026},
volume = {42},
number = {9},
pages = {1945--1947},
doi = {10.1016/j.cjca.2026.04.016}
}
EUVIMED